Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2021 | Story Nonsindiso Qwabe
“This way please” UFS Clinic nurses point the way. From left to right: Sister Nangamso Lukhubeni, Sister Noluthando Luthuli, Sister Mathapelo Moloi, and Sister Modiehi Moloi.

Fully vaccinated! 

These were the words uttered by many Qwaqwa staff members who received their second Pfizer jab at the vaccination site on the Qwaqwa Campus on Thursday (2 September 2021). More than 100 staff members turned up at the site, many for the second jab, while others were there to get their first. The staff members were full of praise for the convenience of having a site on campus, and said the brisk service made the entire process a breeze. The 24/7 Study Centre on campus was repurposed as a vaccination site at the end of August, bringing much-needed relief to staff and students, as well as the Qwaqwa community.

The vaccination experience

Chelly König, Professional Officer in the Department of Chemistry, urged people to trust the science behind the vaccine and the fact that it works. König also came with her relatives. “I’m fully vaccinated and feeling fantastic. I’d urge anyone who’s still hesitant to trust the sciences; these people know what they are doing. My aunt, who is 62, developed COVID-19 after getting her two jabs, and she didn’t experience any effects at all. It was just like the flu. Seeing her recovery convinced me that the vaccine works.”

Ntswaki Mokoena of Bidvest Prestige Cleaning Services also received her second jab. She said: “I am fully vaccinated and so happy. I’ve experienced no side effects whatsoever, and I encourage people to vaccinate; the vaccine is harmless. They should not listen to naysayers who haven’t even vaccinated.”

Calling on more people to vaccinate 

Sister Mathapelo Moloi, Chief Officer at the campus clinic, said the vaccination drive was a source of pride for the campus. “Our priority is to re-open the campus, so I’m very happy that we are seeing staff and students being willing to get vaccinated.”

“It’s not the first time that there has been hesitancy around the vaccine. Providing information is our priority – to help them understand the side effects and everything pertaining to the vaccine.”

Acting Director of Student Affairs on Qwaqwa Campus, Zakhele Mdluli, said vaccinations would help the university community get back to normal. “I encourage students to get vaccinated so that they are able to come back to campus knowing that everyone is safe. This vaccination is no different from the vaccinations we used to get when we were younger.”

The centre operates Monday to Friday from 08:00 to 15:00. People can pre-register either online at https://vaccine.enroll.health.gov.za or via WhatsApp on +27 0 60 012 3456 and should bring along their identity documents. The site is open to anyone 18 years and older. They can simply walk in – no bookings are required.”

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept